$OBLG
Oblong, Inc.

2023 Q3 Form 10-Q Financial Statement

#000074621023000070 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $872.0K $956.0K
YoY Change -26.41% -28.28%
Cost Of Revenue $650.0K $834.0K
YoY Change -22.71% -9.94%
Gross Profit $224.0K $122.0K
YoY Change -34.88% -70.02%
Gross Profit Margin 25.69% 12.76%
Selling, General & Admin $1.058M $1.519M
YoY Change -29.98% 1.13%
% of Gross Profit 472.32% 1245.08%
Research & Development $5.000K $5.000K
YoY Change -97.84% -98.74%
% of Gross Profit 2.23% 4.1%
Depreciation & Amortization $90.00K $87.00K
YoY Change -84.8% -85.48%
% of Gross Profit 40.18% 71.31%
Operating Expenses $1.063M $5.000K
YoY Change -39.01% -99.74%
Operating Profit -$925.0K -$1.091M
YoY Change -87.08% -87.92%
Interest Expense -$20.00K -$6.000K
YoY Change -500.0%
% of Operating Profit
Other Income/Expense, Net $30.00K $42.00K
YoY Change 500.0%
Pretax Income -$895.0K -$1.049M
YoY Change -87.49% -88.39%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$895.0K -$1.049M
YoY Change -87.49% -88.39%
Net Earnings / Revenue -102.64% -109.73%
Basic Earnings Per Share -$0.30 -$0.78
Diluted Earnings Per Share -$0.30 -$0.78
COMMON SHARES
Basic Shares Outstanding 2.929M shares 2.580M shares
Diluted Shares Outstanding 3.463M shares 2.487M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.800M $6.872M
YoY Change 64.13% 34.56%
Cash & Equivalents $6.766M $6.872M
Short-Term Investments
Other Short-Term Assets $300.0K $836.0K
YoY Change -65.44% -27.3%
Inventory $324.0K $402.0K
Prepaid Expenses
Receivables $157.0K $244.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $7.577M $8.354M
YoY Change 18.48% 6.75%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $0.00
YoY Change -100.0% -100.0%
Goodwill
YoY Change
Intangibles $345.0K $432.0K
YoY Change -50.0% -93.25%
Long-Term Investments
YoY Change
Other Assets $16.00K $22.00K
YoY Change -69.81% 0.0%
Total Long-Term Assets $402.0K $519.0K
YoY Change -58.51% -92.3%
TOTAL ASSETS
Total Short-Term Assets $7.577M $8.354M
Total Long-Term Assets $402.0K $519.0K
Total Assets $7.979M $8.873M
YoY Change 8.35% -39.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $106.0K $136.0K
YoY Change -73.57% -58.15%
Accrued Expenses $974.0K $763.0K
YoY Change -10.48% -21.82%
Deferred Revenue $157.0K $234.0K
YoY Change -72.5% -65.89%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.280M $1.201M
YoY Change -45.9% -49.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $57.00K
YoY Change -100.0% -79.72%
Total Long-Term Liabilities $0.00 $57.00K
YoY Change -100.0% -79.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.280M $1.201M
Total Long-Term Liabilities $0.00 $57.00K
Total Liabilities $1.318M $1.258M
YoY Change -48.54% -52.46%
SHAREHOLDERS EQUITY
Retained Earnings -$227.0M -$226.1M
YoY Change 1.97% 4.94%
Common Stock $233.9M $233.9M
YoY Change 2.74% 2.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.661M $7.615M
YoY Change
Total Liabilities & Shareholders Equity $7.979M $8.873M
YoY Change 8.35% -39.1%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$895.0K -$1.049M
YoY Change -87.49% -88.39%
Depreciation, Depletion And Amortization $90.00K $87.00K
YoY Change -84.8% -85.48%
Cash From Operating Activities -$110.0K -$1.338M
YoY Change -88.6% -11.21%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 4.496M
YoY Change
NET CHANGE
Cash From Operating Activities -110.0K -1.338M
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 0.000 4.496M
Net Change In Cash -110.0K 3.158M
YoY Change -88.59% -313.52%
FREE CASH FLOW
Cash From Operating Activities -$110.0K -$1.338M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$110.0K -$1.338M
YoY Change -88.6% -11.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1596000 usd
us-gaap Gross Profit
GrossProfit
398000 usd
glow Share Based Compensation Arrangement By Share Based Payment Award Options Expired Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredWeightedAverageExercisePrice
285.89
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2065000 shares
CY2023Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.06667
CY2023Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.06667
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
6375 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
6375 shares
CY2023Q2 glow Selling And Marketing Expense Income
SellingAndMarketingExpenseIncome
-58000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.40
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.40
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
25497000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4539000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
52000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
84000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-9033000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
11924000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2268000 usd
us-gaap Net Income Loss
NetIncomeLoss
-13572000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
173000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1226000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-32000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
125000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
77000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
235000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
442000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
83000 usd
glow Forfeiture Of Unvested Stock Options
ForfeitureOfUnvestedStockOptions
0 usd
glow Forfeiture Of Unvested Stock Options
ForfeitureOfUnvestedStockOptions
84000 usd
glow Inventory Write Down Net Of Insurance Proceeds
InventoryWriteDownNetOfInsuranceProceeds
-400000 usd
glow Inventory Write Down Net Of Insurance Proceeds
InventoryWriteDownNetOfInsuranceProceeds
533000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
2000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
179000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
7367000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-203000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-233000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-321000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-210000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-213000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
69000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-18000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-87000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-48000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
66000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-456000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
17000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-259000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-265000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-168000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-282000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2182000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3911000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11000 usd
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
0 usd
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
29000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
18000 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
5435000 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
534000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5969000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3787000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3893000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3085000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6872000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5107000 usd
us-gaap Interest Paid Net
InterestPaidNet
9000 usd
us-gaap Interest Paid Net
InterestPaidNet
6000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
31000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
149000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
glow Warrant Modification
WarrantModification
25000 usd
glow Warrant Modification
WarrantModification
0 usd
glow Stock Issued Conversion Of Preferred Stock
StockIssuedConversionOfPreferredStock
4000 usd
glow Stock Issued Conversion Of Preferred Stock
StockIssuedConversionOfPreferredStock
0 usd
glow Stock Issued Share Based Compensation
StockIssuedShareBasedCompensation
751000 usd
glow Stock Issued Share Based Compensation
StockIssuedShareBasedCompensation
0 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of the Condensed Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. </span></div>We continually evaluate estimates used in the preparation of our consolidated financial statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include determining the allowance for doubtful accounts, the estimated lives and recoverability of intangible assets, the inputs used in the valuation of intangible assets in connection with our impairment test, and the inputs used in the fair value of equity-based awards.
CY2022Q2 us-gaap Inventory Write Down
InventoryWriteDown
533000 usd
CY2023Q2 us-gaap Insurance Recoveries
InsuranceRecoveries
400000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6872000 usd
CY2023Q2 glow Working Capital
WorkingCapital
7153000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2268000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2182000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
690000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
258000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
432000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
690000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
86000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
604000 usd
CY2023Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
87000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
580000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
173000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1160000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
174000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
258000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
432000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
0 usd
CY2022Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
6229000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
7367000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
201000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
707000 usd
CY2023Q2 glow Deposits Current
DepositsCurrent
167000 usd
CY2022Q4 glow Deposits Current
DepositsCurrent
128000 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
0 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
57000 usd
CY2023Q2 glow Accrued Sales Taxes And Regulatory Fees
AccruedSalesTaxesAndRegulatoryFees
41000 usd
CY2022Q4 glow Accrued Sales Taxes And Regulatory Fees
AccruedSalesTaxesAndRegulatoryFees
59000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
15000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
14000 usd
CY2023Q2 us-gaap Accrued Rent Current
AccruedRentCurrent
194000 usd
CY2022Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
109000 usd
CY2023Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
145000 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 usd
CY2023Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
763000 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1074000 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
36000 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
76000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
82000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
215000 usd
CY2023Q2 us-gaap Sublease Income
SubleaseIncome
11000 usd
CY2022Q2 us-gaap Sublease Income
SubleaseIncome
44000 usd
us-gaap Sublease Income
SubleaseIncome
27000 usd
us-gaap Sublease Income
SubleaseIncome
110000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
65000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
142000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
68000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
219000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
68000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
236000 usd
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
73000 usd
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
125000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
173000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
298000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
52000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
17000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
69000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
68000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
659000 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
728000 usd
CY2022 glow Operating Lease Right Of Use Asset Additions
OperatingLeaseRightOfUseAssetAdditions
11000 usd
CY2022 glow Operating Lease Liability Additions
OperatingLeaseLiabilityAdditions
11000 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
349000 usd
CY2022 glow Operating Lease Liability Amortization And Payments
OperatingLeaseLiabilityAmortizationAndPayments
503000 usd
CY2022 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
179000 usd
CY2022 glow Operating Lease Liability Impairment Charges
OperatingLeaseLiabilityImpairmentCharges
0 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
142000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
236000 usd
glow Operating Lease Right Of Use Asset Additions
OperatingLeaseRightOfUseAssetAdditions
0 usd
glow Operating Lease Liability Additions
OperatingLeaseLiabilityAdditions
0 usd
glow Operating Lease Right Of Use Asset Terminations And Modifications
OperatingLeaseRightOfUseAssetTerminationsAndModifications
0 usd
glow Operating Lease Liability Terminations And Modifications
OperatingLeaseLiabilityTerminationsAndModifications
0 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
77000 usd
glow Operating Lease Liability Amortization And Payments
OperatingLeaseLiabilityAmortizationAndPayments
168000 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 usd
glow Operating Lease Liability Impairment Charges
OperatingLeaseLiabilityImpairmentCharges
0 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
68000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2736481 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2728928 shares
CY2023Q2 glow Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
667 shares
CY2023Q2 glow Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
1934 shares
CY2023Q2 glow Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
4137846 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
343099 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
66.34
CY2021Q4 glow Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
343101 shares
CY2021Q4 glow Class Of Warrant Or Right Exercisable Exercise Price Of Warrants
ClassOfWarrantOrRightExercisableExercisePriceOfWarrants
66.34
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
343099 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
66.34
CY2022Q4 glow Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
343101 shares
CY2022Q4 glow Class Of Warrant Or Right Exercisable Exercise Price Of Warrants
ClassOfWarrantOrRightExercisableExercisePriceOfWarrants
66.34
glow Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
4136846 shares
glow Class Of Warrant Or Right Granted Weighted Average Exercise Price
ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice
1.71
glow Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
339498 shares
glow Class Of Warrant Or Right Exercised Weighted Average Exercise Price
ClassOfWarrantOrRightExercisedWeightedAverageExercisePrice
1.71
glow Class Of Warrant Or Right Exercisable Exercised
ClassOfWarrantOrRightExercisableExercised
339500 shares
glow Class Of Warrant Or Right Exercisable Exercised Weighted Average Exercise Price
ClassOfWarrantOrRightExercisableExercisedWeightedAverageExercisePrice
1.71
glow Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
2601 shares
glow Class Of Warrant Or Right Expired Weighted Average Exercise Price
ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice
76.93
glow Expired
Expired
2601 shares
glow Class Of Warrant Or Right Exercisable Expired Weighted Average Exercise Price
ClassOfWarrantOrRightExercisableExpiredWeightedAverageExercisePrice
76.93
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4137846 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.73
CY2023Q2 glow Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
1000 shares
CY2023Q2 glow Class Of Warrant Or Right Exercisable Exercise Price Of Warrants
ClassOfWarrantOrRightExercisableExercisePriceOfWarrants
64.50
CY2023Q2 glow Preferred Stock Shares Designated
PreferredStockSharesDesignated
1983250 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
6375 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
6375 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
3336 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
6668 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
501 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
10000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
27169 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
113.63
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
7169 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0 shares
CY2022 glow Share Based Compensation Arrangements By Share Based Payment Award Options Vested In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
3332 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
48.75
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
501 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
410.18
CY2022 glow Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodNumberOfShares
501 shares
CY2022 glow Share Based Compensation Arrangement By Share Based Payment Award Options Expired Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredWeightedAverageExercisePrice
410.18
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
10000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
48.75
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16668 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
143.63
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
10000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
206.85
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0 shares
glow Share Based Compensation Arrangements By Share Based Payment Award Options Vested In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
3336 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
48.75
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
6668 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
285.89
glow Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodNumberOfShares
6668 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
48.75
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6668 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
48.75
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
123000 usd
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1049000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-9033000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2268000 usd
us-gaap Net Income Loss
NetIncomeLoss
-13572000 usd
CY2023Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
149000 usd
CY2022Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
149000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 usd
CY2023Q2 glow Warrants Conversions Inducements
WarrantsConversionsInducements
751000 usd
CY2022Q2 glow Warrants Conversions Inducements
WarrantsConversionsInducements
0 usd
glow Warrants Conversions Inducements
WarrantsConversionsInducements
751000 usd
glow Warrants Conversions Inducements
WarrantsConversionsInducements
0 usd
CY2023Q2 us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
0 usd
CY2022Q2 us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
0 usd
us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
25000 usd
us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
0 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1949000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9033000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3193000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13572000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2487000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2487000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2065000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2065000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2277000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2277000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2065000 shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.78
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.78
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.37
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.40
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.40
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.57
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.57
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
956000 usd
CY2023Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
834000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
122000 usd
CY2023Q2 glow Gross Profit Percentage
GrossProfitPercentage
0.13
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
1213000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1091000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
42000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1049000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1049000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1333000 usd
CY2022Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
926000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
407000 usd
CY2022Q2 glow Gross Profit Percentage
GrossProfitPercentage
0.31
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
9440000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9033000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9033000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-9033000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1994000 usd
glow Gross Profit Percentage
GrossProfitPercentage
0.20
us-gaap Costs And Expenses
CostsAndExpenses
2692000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2294000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
64000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2230000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2268000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2865000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1959000 usd
us-gaap Gross Profit
GrossProfit
906000 usd
glow Gross Profit Percentage
GrossProfitPercentage
0.32
us-gaap Costs And Expenses
CostsAndExpenses
14461000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-13555000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13561000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 usd
us-gaap Net Income Loss
NetIncomeLoss
-13572000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
956000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1333000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1994000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2865000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1994000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2865000 usd

Files In Submission

Name View Source Status
0000746210-23-000070-index-headers.html Edgar Link pending
0000746210-23-000070-index.html Edgar Link pending
0000746210-23-000070.txt Edgar Link pending
0000746210-23-000070-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
glow-20230630.htm Edgar Link pending
glow-20230630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
oblg-ex311_20230630xq2.htm Edgar Link pending
oblg-ex312_20230630xq2.htm Edgar Link pending
oblg-ex321_20230630xq2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
glow-20230630_lab.xml Edgar Link unprocessable
glow-20230630_pre.xml Edgar Link unprocessable
glow-20230630_htm.xml Edgar Link completed
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
glow-20230630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
glow-20230630_def.xml Edgar Link unprocessable